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Abstract
Mutations in Notch3 are the cause of cerebral autosomal
dominant arteriopathy with subcortical infarcts and leu-
koencephalopathy (CADASIL), an inherited small vessel
disease leading to subcortical strokes and vascular de-
mentia. The phenotypic presentation is variable but re-
markable for a high frequency of migraine with aura.
Magnetic resonance images show a microangiopathic
pattern of lesions. Prominent involvement of the tempo-
ropolar white matter and involvement of the temporopo-
lar arcuate fibers are conspicuous findings seen in many
patients. The underlying angiopathy is characterized by
a unique type of ultrastructural basal lamina deposits
and by degeneration of vascular smooth muscle cells
which are the major source of Notch3 expression. In line
with these findings there is evidence for a functional
impairment of vascular smooth muscle cells. CADASIL
has opened a new perspective in studying basic mecha-
nisms of vessel wall degeneration and ischemic tissue
damage related to small vessel disease.
Copyright © 2002 S. Karger AG, Basel
Introduction
In 1977, Sourander and Walinder [1] presented clinical
and pathological findings on 5 nonhypertensive patients
who had experienced recurrent ischemic strokes with
onset before age 40. Four of them developed progressive
dementia. Post-mortem studies revealed multiple small
infarcts and diffuse white matter changes as well as vascu-
lar alterations most prominent in small muscular arteries.
Because of multiple affected family members in three suc-
cessive generations the authors suspected an autosomal
dominant mode of transmission. Subsequently, addition-
al families with similar clinical and pathological findings
were described [2–7]. A major breakthrough was achieved
in 1993, when Tournier-Lasserve et al. [8] mapped the
disease gene locus to chromosome 19 using a positional
cloning approach. Since then, CADASIL (cerebral autoso-
mal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy) has become the accepted acronym
for the condition. Moreover, the number of families iden-
tified increased dramatically (several hundred in a few
years). Narrowing of the disease gene locus [9, 10] eventu-
ally led to the identification of the responsible gene as
Notch3 [11]. It further became clear that expression of
Notch3 is strongly restricted to vascular smooth muscle
cells (VSMC) – a key element in small vessel pathology
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[12]. This has opened an entire avenue for studying the
mechanisms of vessel wall degeneration and microan-
giopathy-related cerebral damage.
Clinical Phenotype
In most cases, CADASIL patients present with one of
the following four manifestations: ischemic episodes, cog-
nitive deficits, migraine with aura and psychiatric distur-
bance.
Ischemic episodes (TIA or stroke) are the most fre-
quent presentation found in about 85% of symptomatic
individuals [13–15]. Mean age at onset for ischemic epi-
sodes is around 46 years with a range of about 30–70
years. In many cases they present as a classic lacunar syn-
drome (pure motor stroke, ataxic hemiparesis, dysarthria
– clumsy hand syndrome, pure sensory stroke, sensorimo-
tor stroke) but other ischemic syndromes (brainstem or
hemispheric) are also observed. They are often recurrent
leading to severe disability with gait disturbance, urinary
incontinence and pseudobulbar palsy. Strokes involving
the territory of a large artery have occasionally been
reported [16]. However, such observations may be coinci-
dental. Without doubt, strokes related to small vessel
pathology are the main manifestation of the disease.
Cognitive deficits are the second most frequent feature
observed in about 60% of symptomatic individuals. By
the age of 65 years, two thirds of the patients have become
demented [13]. Cognitive impairment includes deficits in
episodic memory, attention, executive and visuospatial
functions, usually accompanied by psychomotor slowing
and a narrowing of the field of interest. In most cases, cog-
nitive decline is slowly progressive with additional step-
wise deterioration.
Migraine with aura is among the early manifestations
of CADASIL and is found in about 30% of patients. Aura
symptoms tend to prefer the visual and sensory system.
However, in a considerable number of cases, symptoms
are those of hemiplegic migraine, basilar migraine or iso-
lated aura which may be difficult to differentiate from
ischemic episodes. In fact, the relationship between ‘mi-
graine with aura’ and ‘TIA with headache’ is an important
pathophysiologic aspect of the disease. In an individual
patient the type of aura may vary or be invariantly the
same. In most patients who develop migraine, it is the
first symptom (onset usually before age 40 years). Also,
the frequency of migraine attacks seems to decrease after
the first stroke [13].
Mood disorders are the most frequent psychiatric man-
ifestations and occur in about 30% of the cases. Apart
from adjustment disorders, patients may develop severe
major depression. Other manifestations include manic-
depressive disorder, panic disorder, hallucinatory syn-
dromes and delusional episodes. Five to 10% of the
CADASIL patients develop epileptic seizures which may
require treatment. There have been single reports on spi-
nal cord signs [17] or infarcts [1, 18] as well as intracere-
bral hemorrhages [1, 19]. However, these are single obser-
vations.
The overall course of CADASIL is highly variable,
even within single families. Some patients remain asymp-
tomatic until their 70s whereas others are severely dis-
abled by the age of 50. Early onset does not necessarily
predict rapid progression. In a large population of pa-
tients the duration from onset to death varied between 3
and 43 (mean 23) years [13]. Advanced stages correspond
to the clinical syndrome of severe Binswanger’s encepha-
lopathy [20]. Mean age at death is about 60 years [13–
15].
Neuroimaging
MRI reveals two major types of abnormalities, the first
being sharply demarcated regions that are isointense to
CSF on T1- and T2-weighted images. Many of these
lesions are suggestive of lacunar infarcts regarding size,
shape and location (basal ganglia, thalamus, internal cap-
sule and brainstem, in particular pons). The second type
of abnormality consists of less well-demarcated T2-hyper-
intensities of variable size that may show different de-
grees of hypointensity on T1-weighted images but are
clearly distinct from CSF. The majority of these lesions
are located in the subcortical white matter. However, sim-
ilar lesions may also be seen in other brain regions includ-
ing the subcortical gray matter [21, 22]. Small irregular T2
hyperintensities of the periventricular and deep white
matter are usually the first sign seen in younger individu-
als. As individuals get older, lesions tend to become con-
fluent eventually affecting a large proportion of the white
matter. In addition, patchy areas of variable T1-signal
hypointensity become apparent within confluent lesions,
indicating progressive tissue damage within T2-visible
lesions. Apparently, the onset of MRI visible lesions and
the rate of progression show considerable variation [14,
23], even though by about age 35 years all gene carriers
have developed lesions on MRI [14]. The pattern of MRI
lesions [21, 24] shares many similarities with sporadic
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small vessel disease. However, there are two important
signs that have turned out to be particularly helpful in the
identification of disease gene carriers: (i) T2-signal hyper-
intensities within the temporopolar white matter [22, 25],
and (ii) involvement of the subcortical U-fibers within
temporopolar and superior frontal regions [22]. In con-
junction with the clinical data (including family history
and risk factors) those features may help in selecting
patients for specific diagnostic tests (see below). Conven-
tional angiography is not helpful. Moreover, CADASIL
patients are at an increased risk of developing angiograph-
ic complications [26].
Studies on brain perfusion and brain metabolism
found reductions of cerebral blood flow, cerebral blood
volume and cerebral glucose utilization [27–31]. These
findings are in agreement with chronic ischemia, likely to
play a prominent role in the development of CADASIL
lesions. Moreover, two recent studies found marked im-
pairment of cerebral vasoreactivity [27, 28] consistent
with the degeneration of VSMC in small arteries and arte-
rioles. Also, the arterio-venous cerebral transit time was
found to be markedly prolonged in CADASIL patients
compared to controls [42].
Using different approaches such as magnetic reso-
nance spectroscopy [32], diffusion tensor imaging [33]
and magnetization transfer imaging [34], recent studies
have provided converging evidence for subtle tissue alter-
ations outside T2-visible lesions both in the white and
gray matter including cortex. Moreover, these studies
indicate various degrees of tissue damage (demyelination,
axonal loss, gliosis, enlargement of the extracellular
spaces) in T2 lesions. Quite importantly, both the total
volume of lesions [23, 34] and the extent of signal altera-
tions within lesions [32–34] were shown to correlate with
clinical parameters, indicating that these metrics might be
used as outcome measures in future therapeutic trials.
Pathology
Most autopsy studies have been carried out on patients
with advanced disease. In such cases, macroscopic exami-
nation of the brain reveals a pronounced rarefaction of
the subcortical white matter with periventricular prefer-
ence [35]. Other consistent findings are lacunar infarcts
located predominantly within the basal ganglia, thalamus
and brainstem (in particular the pons). Histopathological
examination shows various degrees of demyelination, ax-
onal loss, enlargement of the extracellular space and mild
astrocytic gliosis compatible with chronic ischemia. The
underlying vascular lesion is a unique nonarteriosclerotic,
amyloid-negative angiopathy involving small arteries
(100–400 Ìm) and capillaries primarily in the brain but
also in other organs. The diagnosis may therefore be
established by a simple skin biopsy [43]. Ultrastructural
examination reveals characteristic granular osmiophilic
deposits within the vascular basal lamina which are con-
sidered diagnostic. These deposits are often seen in direct
contact with VSMC which degenerate and eventually dis-
appear. Yet they have not been characterized biochemi-
cally and their origin remains unresolved. Even though
CADASIL is a generalized angiopathy, vascular compli-
cations appear to be limited to the brain. This discrepancy
might in part be related to the predominant involvement
of leptomeningeal and long penetrating arteries of the
brain. However, additional factors such as properties of
the blood-brain barrier may be suspected [35, 36].
The Molecular Basis of CADASIL
CADASIL patients carry mutations in the Notch3 gene
which is one of four known homologues of Drosophila
Notch [11, 37]. Like all Notch genes, Notch3 codes for a
large single-pass transmembrane receptor. The Notch sig-
naling pathway has been shown to be essential for em-
bryonic development in vertebrates and invertebrates. By
interaction with their extracellular ligands, Notch recep-
tors mediate cell-cell interactions that specify cell fate
decisions during development [38].
A constant feature of Notch receptors is a large number
of tandemly arranged epidermal growth factor-like (EGF-
like) repeat domains which account for most of the extra-
cellular domains of these proteins. All CADASIL muta-
tions are located in EGF-like repeat domains of the
Notch3 receptor with a strong cluster at the N-terminus
[39, 40]. Mutations show a strikingly stereotyped nature:
all mutations lead to the gain or loss of an uneven number
of cysteine residues [39–41]. Since each wtEGF repeat
domain contains six cysteines, these mutations result in
an odd number of cysteine residues within one EGF
domain. It has been suggested that the unpaired cysteine
residue generated by the mutations could cause aberrant
interactions of Notch3 with other Notch3 molecules or
other proteins, and in fact, recent data have provided evi-
dence for multimerization of mutant Notch3 [12].
The expression of Notch3 is restricted to VSMC in
human adult tissues. In CADASIL there is an excessive
accumulation of the ectodomain of the Notch3 receptor
within blood vessels [12]. Accumulation takes place at the
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cytoplasmic membrane of VSMC and pericytes, in close
vicinity to but not within the granular osmiophilic depos-
its. These findings underline the central role of VSMC
pathology in CADASIL, in line with functional investiga-
tions evidencing VSMC dysfunction in vivo [28].
Conclusion
CADASIL has been recognized as a surprisingly fre-
quent condition. The responsible genetic defect has been
identified and the pivotal role of VSMC has been firmly
established. A number of challenging questions remain:
(i) What are the mechanisms leading to Notch3 recep-
tor aggregation? (ii) What causes VSMC to degenerate?
(iii) What are the molecular components contained with-
in the granular deposits? (iv) How are the sequences of
events that eventually cause lacunar infarcts and diffuse
tissue alterations visible at autopsy? Some of these ques-
tions may be answered in appropriate animal models.
Little is known about the mechanisms underlying mi-
graine in CADASIL. Studies on the pathophysiology of
migraine in CADASIL may provide important insights
into the more common aspects of migraine, in particular
migraine with aura. Other important issues include the
determinants of subcortical vascular dementia, and the
identification of factors influencing disease progression.
Obviously the greatest challenge will be to identify an
effective treatment for this frequently devastating condi-
tion.
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